Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic Syndromes
1987 • 653 citations
Clonal analysis using recombinant DNA probes from the X-chromosome.
1987 • 439 citations
Phase I/II study of recombinant human granulocyte-macrophage colony- stimulating factor in aplastic anemia and myelodysplastic syndrome
1988 • 301 citations
Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia
1980 • 292 citations
Treatment of Myelodysplastic Syndromes with Recombinant Human Granulocyte Colony-Stimulating Factor
1989 • 208 citations
Purified colony stimulating factors (G‐CSF and GM‐CSF) induce differentiation in human HL60 leukemic cells with suppression of clonogenicity
1987 • 125 citations
Effect of chemotherapy for the dysmyelopoietic syndrome.
1981 • 112 citations
In vivo inhibition of the development of myeloid leukemia by injection of macrophage‐and granulocyte‐inducing protein
1981 • 110 citations
Autoinduction of differentiation in wehi‐3B leukemia cells
1982 • 105 citations
Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts.
1989 • 100 citations
Solid-phase radioimmune assay
1972 • 71 citations
EVOLUTION OF THE MYELODYSPLASTIC SYNDROMES
1986 • 62 citations
Control of in vivo differentiation of myeloid leukemic cells. iv. inhibition of leukemia development by myeloid differentiation‐inducing protein
1984 • 58 citations
Subacute myeloid leukemia
1979 • 58 citations
Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
1990 • 40 citations
Cited By (0)
No citing papers found in database